NCT05171803View on ClinicalTrials.gov

Investigating Immune Escape by SARS-CoV-2 Variants

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

May 29, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

October 15, 2023

Conditions
COVID-19; Immunity
Interventions
OTHER

No intervention

No intervention, prospective, cohort study.

Trial Locations (1)

91773

Curative, San Dimas

Sponsors

Collaborators (1)

Advarra
All Listed Sponsors
collaborator

Advarra

INDUSTRY

lead

University of California, Los Angeles

OTHER

NCT05171803 - Investigating Immune Escape by SARS-CoV-2 Variants | Biotech Hunter | Biotech Hunter